Reversible ileitis secondary to high dose intravenous immunoglobulin in adult kidney transplant patient treated for acute humoral rejection

Transplant International

Volumn 24, Issue 12, 2011, Pages

  Ignace Girerd, Sophie ^a,b   Bouffard, Juliette ^a   Du Besset, Anne Claire ^a,b   Giannoli, Catherine ^c   Cahen, Rémi ^a   Dijoud, Frédérique ^d   Pouteil Noble, Claire ^a,b   Villar, Emmanuel ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

acute humoral rejection; ileitis; intravenous immunoglobulin; kidney transplantation

Indexed keywords

AMLODIPINE; BORTEZOMIB; CYCLOSPORIN; ESOMEPRAZOLE; EVEROLIMUS; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEBIVOLOL; PREDNISONE; RAMIPRIL; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC ALLOGRAFT NEPHROPATHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG WITHDRAWAL; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; HYPERTENSION; ILEITIS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROPHYLAXIS;

ACUTE DISEASE; ADULT; GRAFT REJECTION; HUMANS; ILEITIS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80755139629     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01343.x     Document Type: Article

References (17)

1. Colvin RB,. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046.
2. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033.
3. Katz U, Achiron A, Sherer Y, Shoenfled Y,. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 2007; 6: 257.
4. Navarro M, Negre S, Matoses ML, Golombek SG, Vento M,. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease in the newborn. Acta Paediatr 2009; 98: 1214.
5. Figuera-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet-Mussons F, Carbonell-Estrany X,. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 2010; 125: 139.
6. Chapman SA, Golkerson KL, Davin TD, Pritzker MR,. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilzed, but not with d-sorbitol-stabilized, formulation. Ann Pharmacotherapy 2004; 38: 2059.
7. Marie I, Maurey G, Hervé F, Hellot MF, Levesque H,. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol 2006; 155: 714.
8. Bab R,. Effect of immunoglobulin therapy on blood viscosity and potential concerns of thromboembolism, especially in patients with acute Kawasaki disease. Recent Pat Cardiovasc Drug Discov 2008; 3: 141.
9. Lehrich RW, Rocha PN, Reinsmoen N, et al. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 2005; 66: 350.
10. White NB, Greenstein S, Cantafio AW, et al. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 2004; 78: 772.
11. Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 2008; 86: 1754.
12. Karri V, Khan SL, Wilson Y,. Bowel perforation as a presenting feature of pheochromocytoma: case report and literature review. Endocr Pract 2005; 11: 385.
13. Garrido E, Sanromán AL, Rodríguez-Gandía MA, et al. Optimized protocol for diagnosis of acute ileitis. Clin Gastroenterol Hepatol 2009; 7: 1183.
14. Macari M, Balthazar EJ,. CT of bowel wall thickening: significance and pitfalls of interpretation. Am J Roentgenol 2001; 176: 1105.
15. Reinhart WH,. Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 1992; 339: 662.
16. Dalakas MC,. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 1994; 44: 223.
17. Doss-Esper CE, Singhal AB, Smith MS, Henderson GV,. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome. J Neuroimaging 2005; 15: 188.